A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors

Journal of B.U.ON.

Volumn 15, Issue 3, 2010, Pages 514-517

  Aydin, M ^a   Tandogdu, Zafer ^a   Kurtulus, F O ^a   Avci, E ^a   Fazlioglu, A ^a   Cek, M ^a  

^a Taksim Teaching Hospital   (Turkey)

Author keywords

Bladder neoplasm; Non muscle invasive; Second transurethral resection; Staging

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TUMOR; CANCER STAGING; HUMAN; MAJOR CLINICAL STUDY; SUPERFICIAL CANCER; TRANSURETHRAL RESECTION; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSPECTIVE STUDIES; REOPERATION; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 77957724469     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Klan R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 1991; 146: 316-318.
2. Mersdorf A, Brauers A, Wolff J M et al. 2nd TUR for superficial bladder cancer: a must? J Urol 1998; 143 (Suppl 159): 542 (abstr).
3. Kurth KH, Bouffioux C, Sylvester R et al. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol 2000; 37 (Suppl 3): 1-9. (Pubitemid 30248573)
4. Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999; 162: 74-76.
5. Cookoson MS, Herr HW, Zhang ZF et al. The treated natural history of high risk superficial bladder cancer: 15 year outcome. J Urol 1997; 158: 62-67.
6. Henay NM, Nocks BN, Daly JJ et al. Ta and T1 bladder cancer, location, recurrence and progression. Br J Urol 1982; 54: 152-157.
7. Loening S, Slymen D, Narayana A. Analysis of bladder tumor recurrence in 178 patients. Urology 1980; 16: 137-141.
8. Brausi M, Collete L, Kurth KH et al. Variability in the recurrence rate at first follow up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 2002; 41: 523-531.
9. Brauers A, Buettner R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 2001; 165: 808-810.. (Pubitemid 32156283)
10. Brausi M, Kurth K, van der Meijden AP, Sylvester RJ, Collette L. Variability in the three month recurrence rate after TUR in superficial transitional cell carcinoma of the bladder: a combined analysis of 8 EORTC studies. J Urol 1998; 159 (Suppl): 143 (abstr).
11. Koloszy Z. Histopathological "self control" in transurethral resection of bladder tumors. Br J Urol 1996; 67: 162-164.
12. Parmar MKB, Freedman LS, Hargreave TB et al. Prognostic factors for recurrence and follow up policies in the treatment of superficial bladder cancer. Report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol 1989; 142: 284-288.
13. Fitzpatrick JM, West AB, Butler MR et al. Superficial bladder tumors: the importance of recurrence pattern following initial resection. J Urol 1986; 135: 920-922.
14. Hartwig ES, Sivaprakasam S, Florian M, Rudolf H. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006; 97: 1199-1201. (Pubitemid 43907321)
15. Sehwaibold H., Treiber U, Kübler H et al. Significance of 2nd transurethral resection for T1 bladder cancer. Eur Urol 2000; 37 (Suppl 2): 11 (abstr).
16. Oosterlinck W, Kurth KH, Schröder F et al. A prospective EORTC Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol 1993; 149: 749-752.
17. Zurkichen MA, Sulser T, Gaspert A et al. Second transurethral resection of superficial transitional cell carcinoma of the bladder: A must even for experienced urologists. Urol Int 2004; 72: 99-102.
18. Grimm MO, Steinhoff C, Simon X et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long term observational study. J Urol 2003; 170: 433-437. (Pubitemid 36870218)
19. Dalbagni G, Herr HW, Reuter VE. Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 2002; 60: 822-824.
20. Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to Bacillus Calmette-Guerin therapy. J Urol 2005; 174: 2134-2137.
21. Fujii Y, Kawakami S, Koga F et al. Long term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 2003; 92: 559-562.
22. Soloway M, Bruck DS, Kim SS. Expectant management of small recurrent, non-invasive papillary bladder tumours. J Urol 2003; 170: 438-441. (Pubitemid 36870219)